Rule 3, Drugs (Prices Control) Order, 2013: Directions to manufacturers of active pharmaceutical ingredients or bulk drugs or formulations
Drugs (Prices Control) Order, 2013 - Rule 3
Text of rule 3
Directions to manufacturers of active pharmaceutical ingredients or bulk drugs or formulations
3. Directions to manufacturers of active pharmaceutical
ingredients or bulk drugs or formulations.– The Government
may, - (i) with a view to achieve adequate availability and to
regulate the distribution of drugs, in case of emergency or in
circumstances of urgency or in case of non-commercial use in public
interest, direct any manufacturer of any active pharmaceutical
ingredient or bulk drug or formulation to increase the production and
to sell such active pharmaceutical ingredient or bulk drug to such
other manufacturer(s) of formulations and to direct formulators to
sell the formulations to institutions, hospitals or any agency as the
case may be;
(ii) for the purpose of giving any direction under sub-paragraph (i),
call for such information from manufacturers of active
pharmaceutical ingredients or bulk drugs or formulations, as it may
2 Substituted vide GSR 686(E), w.e.f. 09-03-2015
the same drug of specified dosages and strengths as listed in the
National List of Essential Medicines.
[(v) "non-scheduled formulation" means a formulation, which is
not included in Schedule - 1.]2
(w) “pharmacoeconomics” means a scientific discipline that
compares the therapeutic value of one pharmaceutical drug or drug
therapy to another;
(x) "price list" means a price list referred to in paragraphs 24 and
25 and includes a supplementary price list;
(y) “price to retailer” means the price of a drug at which it is sold
to a retailer which includes duties and does not include local taxes;
(z) "retail price" means the price fixed by the Government for a
new drug under paragraph 5;
(za) "retailer" means a dealer carrying on the retail business of sale
of drugs to customers;
(zb) “scheduled formulation" means any formulation, included in
the First Schedule whether referred to by generic versions or brand
name;
(zc) "schedule" means a Schedule appended to this Order;
(zd) "wholesaler" means a dealer or his agent or a stockist
engaged in the sale of drugs to a retailer, hospital, dispensary,
medical, educational or research institution or any other agency;
(ze) “wholesale price index” means annual wholesale price index
of all commodities as announced by the Department of Industrial
Policy and Promotion, Government of India, from time to time.
(2) All other words and expressions used herein and not defined but
defined in the Act or the Drugs and Cosmetics Act, 1940 (23 of
1940) shall have the meanings respectively assigned to them in the
said Acts.
3. Directions to manufacturers of active pharmaceutical
ingredients or bulk drugs or formulations.— The Government
may, - (i) with a view to achieve adequate availability and to
regulate the distribution of drugs, in case of emergency or in
circumstances of urgency or in case of non-commercial use in public
interest, direct any manufacturer of any active pharmaceutical
ingredient or bulk drug or formulation to increase the production and
to sell such active pharmaceutical ingredient or bulk drug to such
other manufacturer(s) of formulations and to direct formulators to
sell the formulations to institutions, hospitals or any agency as the
case may be;
(ii) for the purpose of giving any direction under sub-paragraph (i),
call for such information from manufacturers of active
pharmaceutical ingredients or bulk drugs or formulations, as it may
* Substituted vide GSR 686(E), w.e.f. 09-03-2015
consider necessary and such manufacturer shall furnish the required
information within such time the Government may fix.
Previous and next
Questions people ask
Is rule 3 of Drugs (Prices Control) Order, 2013 still in force?
No repeal of Drugs (Prices Control) Order, 2013 is recorded.